AmpliChip Microarray Could Take De Novo Premarket Route, FDA Tells Roche
This article was originally published in The Gray Sheet
Executive Summary
Roche must submit a 510(k) application before commercializing its AmpliChip CYP450 microarray, FDA says in a letter clarifying its regulatory stance on the technology